Effect of intradermal injection of heparinase III on skin wound healing in diabetic rats
- 1 August 2014
- journal article
- research article
- Vol. 149 (4) , 427-433
Abstract
Aim. Impaired wound healing is a major complication of diabetes. It is mainly attributed to neuropathy and vascular damage in this disease. Heparanase is an endoglycosidase that degrades heparan sulfate in the extracellular matrix and is believed to promote angiogenesis. The present study has been performed to investigate the effect of heparinase III (an enzyme which exclusively cleaves heparan sulfate) on wound healing in diabetic rats. Methods. The rats became diabetic by a single streptozotocin injection. Two weeks later, a wound was created by excision of the skin in the left paravertebral area. Heparinase III (0.2 unit) was injected intradermally around the wound every 5 days, starting on day one, for a total of three doses. The wound area was measured every 3 days. After completion of wound healing, full thickness skin samples were taken from the wound sites and evaluated for volume density of the collagen bundles, numerical density of the fibroblasts, and length density of the vessels. Results. Heparinase III accelerated wound closure compared to control diabetic animals. Microscopical examination revealed that it increased angiogenesis with no significant effect on collagen density and the number of fibroblasts. Conclusion. Heparinase III induces angiogenesis and improves wound healing in diabetic animal model.Keywords
This publication has 13 references indexed in Scilit:
- Azelnidipine, a New Calcium Channel Blocker, Promotes Skin Wound Healing in Diabetic RatsJournal of Surgical Research, 2011
- A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac researchCardiovascular Pathology, 2010
- Heparanase involvement in physiology and diseaseCellular and Molecular Life Sciences, 2008
- Statins may be useful in diabetic foot ulceration treatment and preventionMedical Hypotheses, 2007
- Stereological methods to assess tissue response for tissue-engineered scaffoldsBiomaterials, 2007
- Heparan sulphate proteoglycans: the sweet side of developmentNature Reviews Molecular Cell Biology, 2005
- Heparanase expression during normal liver development and following partial hepatectomyThe Journal of Pathology, 2004
- Heparanase mRNA expression during fracture repair in miceHistochemistry and Cell Biology, 2003
- Functional structure and composition of the extracellular matrixThe Journal of Pathology, 2003
- Heparanase as mediator of angiogenesis: mode of actionThe FASEB Journal, 2001